3,3-dimethylbutan-1-ol has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, H; Huang, H; Jiang, X; Kong, B; Shuai, W; Wang, G | 1 |
| Li, X; Sun, Y; Wang, J; Zhang, X | 1 |
2 other study(ies) available for 3,3-dimethylbutan-1-ol and Cardiac Failure
| Article | Year |
|---|---|
3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Echocardiography; Electrocardiography; Fibroblasts; Heart; Heart Failure; Hemodynamics; Hexanols; Inflammation; Male; Methylamines; Mice; Mice, Inbred C57BL; Myocardium; Pressure; Signal Transduction; Transcription Factor RelA; Transforming Growth Factor beta1; Ventricular Remodeling | 2020 |
Reductions in gut microbiota‑derived metabolite trimethylamine N‑oxide in the circulation may ameliorate myocardial infarction‑induced heart failure in rats, possibly by inhibiting interleukin‑8 secretion.
Topics: Animals; Gastrointestinal Microbiome; Heart Failure; Hexanols; Interleukin-8; Male; Methylamines; Myocardial Infarction; Rats; Rats, Sprague-Dawley | 2019 |